Name | Trenbolone Acetate |
Synonyms | ru1697 RU 1697 Finaplix finaplix Revalor-H revalor-h Finaplix-S Finaplix H BRN 2012395 Component T-H Component T-S UNII-RUD5Y4SV0S Trenbolone Acetate trienboloneacetate Trienbolone acetate Trenbolone Acetate API Revalor-H Trenbolone acetate Trenbolone Acetate(Revalor-H) 3-oxoestra-4,9,11-trien-17-yl acetate 3-Oxo-17beta-acetoxyestra-4,9,11-triene 17-beta-(Acetyloxy)estra-4,9,11-trien-3-one 17-beta-Acetoxy-delta-4,9,11-estratrien-3-one (17beta)-3-oxoestra-4,9,11-trien-17-yl acetate 17-beta-Hydroxyestra-4,9,11-trien-3-one acetate 17beta-Hydroxyestra-4,9,11-trien-3-one, acetate 17beta-Hydroxyestra-4,9,11-trien-3-one 17-acetate Estra-4,9,11-trien-3-one, 17-beta-hydroxy-, acetate Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17beta)- |
CAS | 10161-34-9 |
EINECS | 233-432-5 |
InChI | InChI=1/C20H24O3/c1-12(21)23-19-8-7-18-17-5-3-13-11-14(22)4-6-15(13)16(17)9-10-20(18,19)2/h9-11,17-19H,3-8H2,1-2H3 |
InChIKey | CMRJPMODSSEAPL-FYQPLNBISA-N |
Molecular Formula | C20H24O3 |
Molar Mass | 312.4 |
Density | 1.1464 (rough estimate) |
Melting Point | 90-92°C |
Boling Point | 392.32°C (rough estimate) |
Specific Rotation(α) | D20 +36.8° (c = 0.37 in methanol) |
Flash Point | 214.8°C |
Vapor Presure | 1.26E-09mmHg at 25°C |
Appearance | neat |
Storage Condition | 0-6°C |
Refractive Index | 1.4618 (estimate) |
Use | Belong to hormonal drugs, protein anabolic agents |
Hazard Symbols | T - Toxic |
Risk Codes | 60 - May impair fertility |
Safety Description | S22 - Do not breathe dust. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | UN 3077 9 / PGIII |
WGK Germany | 3 |
RTECS | KG7753500 |
HS Code | 2937290000 |
light yellow or yellow crystalline powder.
Hormone; Mediates & FineChemicals;Pharmaceuticals;Steroids; Steriod and Hormone;Finished steriod and Hormone; Pharmaceutical raw materials; Pharmaceutical Intermediates; Steroids; Hormonal Steroids; Analytical standards; APIs; trenbolone series;Hormone Drugs; Forensic and veterinary standards; Androgens, anabolic hormones
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
nandrolone derivatives | group Brilinta acetate is a short-acting group Brilinta, which is a derivative of nandrolone, it does not convert to estrogen, but it can have side effects from progesterone (similar to estrogen side effects). There is some liver toxicity. qunbolong can rapidly increase muscle strength and girth, and improve muscle mass. Accelerates the burning of fat and is one of the most powerful internal sterols. Not suitable for beginners to use, very suitable for fat reduction or use during preparation. Tren-bolone acetate is an injectable (general) anabolic steroid derived from zolones. However, its activity is identical to that of its structural mother, so direct comparison between the two is difficult. Trenbolone acetate is a non-estrogenic steroid that is more anabolic and androgenic than nandrolone per milligram. In terms of appearance, it is comparable to androgens such as nosotone, but more common than nolone. It is estimated to be approximately three times more potent than testosterone, making it one of the most commercially manufactured injectable anabolic steroids. In athletes, this steroid is very important for the ability to increase muscle stiffness, raw strength, and without unnecessary increase in water retention and fat mass. It is considered the drug of choice for competitive bodybuilders and is still popular among those who only want to improve their physical fitness. |
History | trenbolone acetate was first closely studied in Roussel-UCLAF, appearing after a series of anabolic steroid experiments. In the early 50's, herxest sold valerone acetate in the UK as Finajet, and Rousel in France sold valerone acetate as fininject. Rousel AG in Germany is the parent company of both companies. Teloblasts acetate is a veterinary drug, but has also been sold as a long-acting ester (see: Parabolan) for human consumption. Almost all of them are used to increase the weight of the cattle to be slaughter and to increase the feed efficiency of the cattle. In short, the drug is used to increase the profit in terms of total weight. Generally used before slaughter, no time limit. As a result of this practice, meat products sold in many parts of the world tend to contain small amounts of residual talbolone metabolites. In the Eighties of the 20th century, when the first popular among American bodybuilders, the drug was trafficked from Europe. It was identified as (correctly) a powerful anabolic and androgenic agent and quickly became the drug of choice among American bodybuilders. Although it was once very hot, in Hoechst-Roussel, the supply of tembolone acetate was abruptly terminated due to the decision to voluntarily stop selling all injectable drug forms. Although unproven, the growing public concern about sports doping may have much to do with this decision, as it was very common to discontinue "controversial" steroids in the late 1980s and early 1990s. This event marked the end of the legal drug of trebolone acetate. |
structural characteristics | trulalong acetate is a modified form of nandrolone. It differs in the introduction of double bonds in carbons 9 and 11, which inhibit aromatization (9-ene), increase the binding affinity of androgens, and slow down their metabolism. The resulting steroid has a stronger anabolic and androgenic effect than nandone. Trituran acetate contains a chemokine modified by the addition of a carboxylic acid ester (acetic acid) to the 17-beta hydroxyl group, allowing slow release of the free steroid at the injection site. |
side effects | triterpenbrone acetate was not aromatized by the body and was not measured to be estrogenic. Notably, however, the steroid showed significant binding affinity for the progesterone receptor (slightly stronger than progesterone itself). Progesterone-related side effects are similar to estrogen, including negative feedback inhibition of testosterone production and enhanced fat storage rates. Progesterone also increases the stimulating effect of estrogen on the growth of breast tissue. There seems to be a strong synergy between these two hormones, so that gynecomastia may even occur under the action of progesterone, without excessive estrogen levels. The use of anti-estrogens that inhibit the estrogenic components of this disease is often sufficient to alleviate gynecomastia caused by progestational anabolic/androgenic steroids. Note that pro-inflammatory side effects will be more common when using other aromatizable steroids. Although classified as anabolic steroids, the acetomeles are still sufficiently androgenic. Side effects of androgens are very often present with the use of this drug and may include oily skin, acne and attacks of body/facial hair growth. Anabolic/androgenic steroids may also aggravate male hair loss. Women are also warned of the potential pathogenic role of anabolic/androgenic steroids. These may include the deepening of sound, menstrual irregularities, changes in skin texture, facial hair development and clitoral enlargement. In addition, the 5-alpha reductase is not capable of metabolizing the triturans acetate, and therefore its relative androgens are not affected by Finasteride or duetamil. |
Use | belongs to hormone drugs, protein anabolic agents calibration instruments and devices; Evaluation methods; Working standards; quality Assurance/Quality Control |